Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2014. Start Trial.
Date Value
October 02, 2026 1.408
October 01, 2026 1.404
September 30, 2026 1.429
September 29, 2026 1.477
September 28, 2026 1.517
September 25, 2026 1.447
September 24, 2026 1.454
September 23, 2026 1.382
September 22, 2026 1.347
September 21, 2026 1.355
September 18, 2026 1.308
September 17, 2026 1.319
September 16, 2026 1.326
September 15, 2026 1.309
September 14, 2026 1.324
September 11, 2026 1.317
September 10, 2026 1.303
September 09, 2026 1.276
September 08, 2026 1.270
September 04, 2026 1.284
September 03, 2026 1.32
September 02, 2026 1.314
September 01, 2026 1.271
August 31, 2026 1.248
August 28, 2026 1.219
Date Value
August 27, 2026 1.212
August 26, 2026 1.219
August 25, 2026 1.217
August 24, 2026 1.192
August 21, 2026 1.196
August 20, 2026 1.200
August 19, 2026 1.204
August 18, 2026 1.182
August 17, 2026 1.155
August 14, 2026 1.158
August 13, 2026 1.117
August 12, 2026 1.106
August 11, 2026 1.131
August 10, 2026 1.124
August 07, 2026 1.151
August 06, 2026 1.097
August 05, 2026 1.121
August 04, 2026 1.102
August 03, 2026 1.120
July 31, 2026 1.104
July 30, 2026 1.128
July 29, 2026 1.140
July 28, 2026 1.116
July 27, 2026 1.062
July 24, 2026 1.036

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Viatris, Inc. 1.426
Johnson & Johnson 7.256
Eli Lilly & Co. 31.76
Merck & Co., Inc. 8.495
Pfizer Inc. 1.860

Price to Book Value Related Metrics